HLT 324-Food and Drug Administration (FDA) Discussion 3
Food and Drug Administration (FDA) Discussion 3
ORDER NOW FOR AN ORIGINAL PAPER!!! . HLT 324-Food and Drug Administration (FDA) Discussion 3
The content, statements, views, and opinions herein are the sole expression of the respective authors and not that of Jones & Bartlett Learning, LLC. Reference herein to any specific commercial product, process, or service by trade name, trademark, manufacturer, or otherwise does not constitute or imply its endorsement or recommendation by Jones & Bartlett Learning, LLC and such reference shall not be used for advertising or product endorsement purposes. All trademarks displayed are the trademarks of the parties noted herein. Nursing Research: Reading, Using, and Creating Evidence, Fourth Edition is an independent publication and has not been authorized, sponsored, or otherwise approved by the owners of the trademarks or service marks referenced in this product.
There may be images in this book that feature models; these models do not necessarily endorse, represent, or participate in the activities represented in
3
the images. Any screenshots in this product are for educational and instructive purposes only. Any individuals and scenarios featured in the case studies throughout this product may be real or fictitious, but are used for instructional purposes only.
The author, editor, and publisher have made every effort to provide accurate information. However, they are not responsible for errors, omissions, or for any outcomes related to the use of the contents of this book and take no responsibility for the use of the products and procedures described. Treatments and side effects described in this book may not be applicable to all people; likewise, some people may require a dose or experience a side effect that is not described herein. Drugs and medical devices are discussed that may have limited availability controlled by the Food and Drug Administration (FDA) for use only in a research study or clinical trial. Research, clinical practice, and government regulations often change the accepted standard in this field. When consideration is being given to use of any drug in the clinical setting, the health care provider or reader is responsible for determining FDA status of the drug, reading the package insert, and reviewing prescribing information for the most up-to-date recommendations on dose, precautions, and contraindications, and determining the appropriate usage for the product. This is especially important in the case of drugs that are new or seldom used.
15833-5
Production Credits VP, Executive Publisher: David D. Cella Executive Editor: Amanda Martin Editorial Assistant: Emma Huggard Senior Production Editor: Amanda Clerkin Senior Marketing Manager: Jennifer Scherzay Product Fulfillment Manager: Wendy Kilborn Composition: S4Carlisle Publishing Services Cover Design: Scott Moden Rights & Media Specialist: Wes DeShano Media Development Editor: Troy Liston Cover Image: © Valentina Razumova/Shutterstock Printing and Binding: LSC Communications Cover Printing: LSC Communications
Library of Congress Cataloging-in-Publication Data Names: Houser, Janet, 1954- author. Title: Nursing research : reading, using, and creating evidence / Janet Houser. Description: Fourth edition. | Burlington, Massachusetts : Jones & Bartlett Learning, [2018] | Includes bibliographical references and index. Identifiers: LCCN 2016038194 | ISBN 9781284110043 Subjects: | MESH: Clinical Nursing Research–methods | Evidence-Based Food and Drug Administration (FDA) Discussion 3